Alterations of these genes occur in approximately 5–10% of CLL patients at diagnosis and, in the case of NOTCH1, SF3B1, and, BIRC3, have shown significant correlations with poor survival in consecutive series. The gene discussed is BIRC3; the disease is B-cell chronic lymphocytic leukemia.